Skip to main content

Table 4 Non-lipid coronary heart disease risk factor changes during the 12-week study

From: Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial

  Intervention Week 11 Week 12 P-value2 P-value3 Change4 P-value5
Systolic BP (mm Hg) ADF 124 ± 4 117 ± 4 0.02 0.85 -7 ± 2 0.51
  Control 119 ± 3 120 ± 4 0.67   1 ± 3  
Diastolic BP (mm Hg) ADF 78 ± 3 72 ± 2 0.03 0.05 -6 ± 2 0.17
  Control 82 ± 4 84 ± 5 0.28   2 ± 6  
Homocysteine (umol/dl) ADF 9 ± 1 9 ± 1 0.37 0.50 0 ± 1 0.21
  Control 9 ± 1 9 ± 1 0.86   0 ± 1  
C-reactive protein (mg/L) ADF 2 ± 1 1 ± 1 0.29 0.01 -1 ± 1 0.01
  Control 1 ± 1 1 ± 1 0.78   0 ± 1  
Adiponectin (ng/ml) ADF 10728 ± 1251 11401 ± 1197 0.58 0.15 672 ± 1191 <0.01
  Control 11350 ± 1369 10509 ± 1316 0.26   -842 ± 623  
Leptin (ng/ml) ADF 25 ± 4 15 ± 3 0.04 0.55 -10 ± 3 0.03
  Control 22 ± 7 18 ± 6 0.07   -4 ± 3  
Resistin (ng/ml) ADF 18 ± 3 15 ± 4 0.15 0.57 -3 ± 3 0.20
  Control 23 ± 4 21 ± 4 0.26   -2 ± 2  
  1. Values reported as mean ± SEM. ADF: Alternate day fasting.
  2. 1Baseline values were not significantly different between intervention groups for any parameter: Independent samples t-test.
  3. 2P-value between week 1 and week 12: Paired t-test.
  4. 3P-value between groups at week 12: Independent samples t-test.
  5. 4Absolute change between week 1 and week 12 values.
  6. 5P-value between groups for absolute change: Independent samples t-test.